B. Heikius

Seroprevalence of Helicobacter pylori Infection in Inflammatory Bowel Disease: Is Helicobacter pylori Infection a Protective Factor?

T. Karttunen, S. Niemelä, R. Karttunen, 2001, Scandinavian journal of gastroenterology.

Elevated pancreatic enzymes in inflammatory bowel disease are associated with extensive disease

T. Karttunen, S. Niemelä, J. Lehtola, 1999, American Journal of Gastroenterology.

Budesonide enema active haemorrhagic proctitis—a controlled trial against hydrocortisone foam enema

U. Turunen, W. Burnham, P. Sipponen, 1994, Alimentary pharmacology & therapeutics.

Hepatobiliary and coexisting pancreatic duct abnormalities in patients with inflammatory bowel disease.

S. Lähde, T. Karttunen, S. Niemelä, 1997, Scandinavian journal of gastroenterology.

Pancreatic duct abnormalities and pancreatic function in patients with chronic inflammatory bowel disease.

S. Lähde, T. Karttunen, S. Niemelä, 1996, Scandinavian journal of gastroenterology.

Simultaneous solubilization of steroid hormones I: estrogens and C21 steroids.

T. Lövgren, L. Sjöblom, B. Lundberg, 1978, Journal of pharmaceutical sciences.

Simultaneous solubilization of steroid hormones II: androgens and estrogens.

T. Lövgren, B. Lundberg, B. Heikius, 1979, Journal of pharmaceutical sciences.

Elevated serum PIIINP and laminin in inflammatory bowel disease indicate hepatobiliary and pancreatic dysfunction.

O. Niemelä, T. Karttunen, S. Niemelä, 2002, Hepato-gastroenterology.